These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6861880

  • 41. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.
    Lozano-Cuenca J, Muñoz-Islas E, González-Hernández A, Centurión D, Cobos-Puc LE, Sánchez-López A, Pertz HH, Villalón CM.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):80-6. PubMed ID: 19356724
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Inactivation of some vasoconstrictor agonists by saphenous vein strips of the dog.
    Paiva MQ, Osswald W.
    J Pharm Pharmacol; 1980 Mar 10; 32(3):227-8. PubMed ID: 6103947
    [No Abstract] [Full Text] [Related]

  • 48. On the mode of action of ergometrine in the isolated dog coronary artery.
    Sakanashi M, Yonemura KI.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):157-60. PubMed ID: 7398759
    [Abstract] [Full Text] [Related]

  • 49. The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein.
    Humphrey PP.
    Br J Pharmacol; 1978 Aug 13; 63(4):671-5. PubMed ID: 28807
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.
    González-Hernández A, Lozano-Cuenca J, Marichal-Cancino BA, MaassenVanDenBrink A, Villalón CM.
    J Headache Pain; 2018 May 25; 19(1):40. PubMed ID: 29802544
    [Abstract] [Full Text] [Related]

  • 52. [Vasoconstrictor effects on isolated vessel segments determined by pressure-volume measurements].
    Weiss A, Koth W, Beer M, Glusa E, Markwardt F.
    Biomed Biochim Acta; 1986 May 25; 45(10):1285-93. PubMed ID: 3566719
    [Abstract] [Full Text] [Related]

  • 53. Properties of intestinal and cutaneous arteries and veins in two-kidney one-clip Goldblatt hypertension.
    Greenberg S.
    Am J Physiol; 1981 Oct 25; 241(4):H525-40. PubMed ID: 7315977
    [Abstract] [Full Text] [Related]

  • 54. Norepinephrine responses in rat renal and femoral veins are reinforced by vasoconstrictor prostanoids.
    de Souza Rossignoli P, Yamamoto FZ, Pereira OC, Chies AB.
    Vascul Pharmacol; 2015 Sep 25; 72():93-100. PubMed ID: 26141930
    [Abstract] [Full Text] [Related]

  • 55. Superficial hand and foot veins show no difference in sensitivity to constrictor agents.
    Aellig WH.
    Clin Pharmacol Ther; 1990 Jul 25; 48(1):96-101. PubMed ID: 2369808
    [Abstract] [Full Text] [Related]

  • 56. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
    Müller-Schweinitzer E.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 25; 295(1):41-4. PubMed ID: 1004641
    [Abstract] [Full Text] [Related]

  • 57. Possible embryogenetical differences of the dog venous system in sensitivity to vasoactive substances.
    Ishikawa N, Ichikawa T, Shigei T.
    Jpn J Pharmacol; 1980 Dec 25; 30(6):807-18. PubMed ID: 6113298
    [Abstract] [Full Text] [Related]

  • 58. Dual effect of dihydroergotamine at vascular 5-hydroxytryptamine receptors in pithed rats.
    Müller H, Glusa E, Markwardt F.
    Pharmacology; 1988 Dec 25; 37(4):248-53. PubMed ID: 2904153
    [Abstract] [Full Text] [Related]

  • 59. A new technique for recording compliance of human hand veins.
    Aellig WH.
    Br J Clin Pharmacol; 1981 Mar 25; 11(3):237-43. PubMed ID: 7213525
    [Abstract] [Full Text] [Related]

  • 60. Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.
    Hanoun N, Saurini F, Lanfumey L, Hamon M, Bourgoin S.
    Br J Pharmacol; 2003 May 25; 139(2):424-34. PubMed ID: 12770948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.